Browse diseases

…natal care and general practice. Sites will implement POCTs for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and/or HIV/syphil…

… Bacterial sexually transmitted infections (STIs), particularly Chlamydia trachomatis and Neisseria gonorrhoeae, remain highly prevalent among indivi…

…ent advances in point-of-care (POC) diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and other STIs pr…

…xis (doxy-PEP) has emerged as an efficacious strategy to reduce Chlamydia trachomatis (C. trachomatis), Neisseria gonorrhoeae (N. gonorrhoeae) and sy…

…Neisseria gonorrhoeae (NG) continues to pose a complex challenge for clinicians, micr…

…yphilis, Mycoplasma genitalium, warts, Mpox, genital herpes and viral hepatitis. Follow-up (FU) visits were scheduled every three and four mont…

…Objectives The global rise in Neisseria gonorrhoeae (NG) infections, particularly oropharyngeal cases, drives treat…

…Objectives Effective surveillance of antimicrobial-resistant Neisseria gonorrhoeae (Ng) is crucial, but culturing is labourious and costly. Focusi…

…y of the FDA-approved 4CMenB vaccine in preventing experimental N. gonorrhoeae infection. Our research team is currently the only in the world…

…axone.Results Over a period of 6 months, a transgender man with gonococcal cervicitis experienced eight episodes of treatment failure despite receivi…

…the costs and cost-effectiveness of screening and treatment for Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic pregnant women in …

…ves Rapid and accurate detection of antimicrobial resistance in Neisseria gonorrhoeae is key for appropriate treatment of gonorrhoea. Nucleic acid am…